Advertisement

European Journal of Pediatrics

, Volume 178, Issue 1, pp 117–118 | Cite as

Tigecycline salvage therapy for ventriculoperitoneal shunt meningitis due to extensively drug-resistant Acinetobacter baumannii

  • Meltem PolatEmail author
  • Aslinur Ozkaya-Parlakay
Correspondence

Abbreviations

CSF

Cerebrospinal fluid

EVD

External ventricular drainage

MIC

Minimum inhibitory concentration

XDR

Extensively drug-resistant

VPS

Ventriculoperitoneal shunt

Notes

Authors’ contributions

MP: drafting of the manuscript and patient management; AOP: review of literature, critical revision, and approval of final draft of the manuscript

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Mastrolia MV, Galli L, De Martino M, Chiappini E (2017) Use of tigecycline in pediatric clinical practice. Expert Rev Anti-Infect Ther 15:605–612CrossRefGoogle Scholar
  2. 2.
    Michalopoulos A, Falagas ME (2010) Treatment of Acinetobacter infections. Expert Opin Pharmacother 11:779–788CrossRefGoogle Scholar
  3. 3.
    Ye S, Zhang C, Lin S (2018) Preliminary experience with tigecycline treatment for severe infection in children. Eur J Pediatr 177:1489–1496CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Pediatric Infectious DiseasesPamukkale University School of MedicineDenizliTurkey
  2. 2.Department of Pediatric Infectious DiseasesHealth Sciences University Ankara Hematology and Oncology Research HospitalAnkaraTurkey

Personalised recommendations